Fig. 1From: Association of metabolic dysfunction-associated fatty liver disease with systemic atherosclerosis: a community-based cross-sectional studyDistributions of atherosclerotic plaques and stenosis and presence of PolyVD in participants. MAFLD, metabolic dysfunction-associated fatty liver disease; PolyVD, polyvascular disease; DM, diabetes mellitus; OW, overweight or obesity. a Extent of atherosclerotic plaques. b Extent of atherosclerotic stenosis. c PolyVDBack to article page